The size of the European dermal fillers market is expected to grow at a compound annual growth rate of 6.7% over the forecast period, reaching approximately USD 1.6 billion by 2025 from 994 million in 2020. The rapid aging of the population, numerous cosmetic surgeries, and technological advances are key factors driving the market. The high per capita disposable income in the region is also a significant factor in market growth.
According to Eurostat, the total adjustable disposable income for households in the EU 28 countries in 2018 was approximately USD 22,840, compared to almost USD 20,400 in 2012. Due to growing demand, several cosmetic operations are being performed to enhance people's aesthetic appeal. It is also due to the availability of non-invasive surgical alternatives and consumer awareness.
The Europe Dermal Fillers Market has a high middle-age population, creating significant opportunities for the market. According to Europe Dermal Fillers Market statistics, about 45% of the European population was between 35 and 64 in 2019. It is expected to result in the fastest growth in the European dermal fillers business. It is the world's largest economy and one of the foremost destinations for dermal fillers worldwide.
The factors for the growth of the dermal fillers market in Europe is that the rise in cosmetic surgeries and demand for beauty products and their production. The advantages of dermal fillers, such as reducing fine lines and wrinkles, volume, and thin and aging lips, drive market growth. After adulthood, the aging problem's primary concern for beauty modification; henceforth, most people forgo the restoration of volume in the cheeks and chin. Sagging skin corrections, scars, and wrinkles treatment for the aged population is also on-demand. As the European community comprises more middle-aged people, the market has been increased as middle-aged are more focused on aesthetic appeal. Furthermore, consumer awareness and non-invasive surgical procedures add on benefits for this market.
In the European dermal filler market, the field of facial line correction is supposed to have the largest market share in the outlook period. It is due to the increasing demand to reduce the effects of aging on the skin. Besides, cosmetic applications include temporary and forehead enlargement and treatment of facial scars, and their adoption is escalating in the dermal filler market its generated opportunity in the market.
Along with market drivers, few market restraints held back market growth. The dermal filling process needs the utmost care and time. Also, complications such as redness, bruising, soreness are challenges for this market. Medical Professionals or cosmetic industry professionals need to handle these processes. The dermal filling procedure is of high cost and is a significant restraint for European countries' market growth. The post-procedure complications associated with dermal fillers like redness, bruising, and granulation is challenges in the local market.
This research report on the European Dermal Fillers Market has been segmented & sub-segmented into the following categories:
By Therapeutic Area:
Based on geography, Europe held the second-largest share of the market in terms of revenue. European countries are at the top level for the dermal fillers market as a vast population has an impact, and more Beauty concerns are addressed. Awareness of aesthetics and beauty in Europe is High than expected. European countries have developed economies that provide medical infrastructure and modern technologies for cosmetic surgeries.
The emerging countries of Europe provide significant offers to improve the healthcare infrastructure. This attribute is also to fuel the growth rate of the market. High spending on healthcare and increasing elderly people are surging the growth rate of the market. High disposable income in this region is escalating the growth rate of the dermal fillers market in Europe.
A growing number of middle-aged people in Europe is anticipated to leverage the demand of the market. For instance, according to United Nations, the middle age people of 35-64 years in 2019 occupied 45% of the total population. This is increasing the demand for dermal fillers in this region. Growing prominence for cosmetic surgeries in the developed developing countries is leveraging the growth rate of the market.
The UK dermal fillers market is expected to lead the European market with the largest shares. Adoption of the latest technologies is likely to bolster the growth rate of the dermal fillers market. The Germany dermal fillers market is next to the UK in dominating the shares of the European dermal fillers market. Growing priority to beautify the face with minimally invasive surgeries is significantly to propel the demand of the market in this country. Government organizations are greatly supporting in approving the innovative products which are merely lavishing the growth rate of the market.
Major companies operating in the Europe Dermal Fillers Market profiled in this report are Allergan Inc., AQTIS Medical, Bioha Laboratories, Suneva Medical, Galderma, Merz Aesthetics, Cynosure, Syneron, and Cytophil Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Absorbable or Biodegradable
5.1.3 Non-Absorbable or Non-Biodegradable
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.3 Deep Facial Lines
5.2.4 Sagging Skin
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.7 Market Attractiveness Analysis, By Therapeutic Area
5.2.8 Market Share Analysis, By Therapeutic Area
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Therapeutic Area
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Therapeutic Area
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Allergan Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AQTIS Medical
8.3 Bioha Laboratories
8.4 Suneva Medical
8.6 Merz Aesthetics
8.9 Cytophil Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures